US Pre-Market SEC Filings Roundup — January 29, 2026

30-01-2026

30-01-2026

Gentex Corp filed an 8-K on January 30, 2026, under Item 2.02 reporting results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, margins, or period-over-period comparisons are disclosed in the provided filing details. This appears to be an earnings-related disclosure with no quantified metrics available.

30-01-2026

ArcBest Corp /DE/ filed an 8-K on January 30, 2026 (AccNo: 0001104659-26-008222, Size: 16 MB), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits provided under Item 9.01. No specific revenue, earnings, margins, period-over-period comparisons, or other quantitative financial metrics are explicitly stated in the provided filing information. This represents a standard earnings-related disclosure with no directional performance indicators available.

• ·File size: 16 MB

30-01-2026

News Corp filed an 8-K on January 30, 2026 (AccNo: 0001564708-26-000020, Size: 399 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other event, transaction, financial impacts, or contents of the exhibits are disclosed. This appears to be a multi-item filing with informational disclosures but lacks quantitative metrics or directional implications.

30-01-2026

30-01-2026

AMERICAN EXPRESS CO filed an 8-K on January 30, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a standard financial results disclosure, but no specific revenue, earnings, margins, guidance, or other quantitative metrics are disclosed in the provided filing information. All detailed financial data remains NOT_DISCLOSED.

30-01-2026

Regeneron Pharmaceuticals, Inc. filed a Form 8-K on January 30, 2026 (AccNo: 0000872589-26-000004, Size: 735 KB), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. This is a multi-item filing focused on financial results disclosure. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information.

30-01-2026

30-01-2026

QuantumScape Corp filed an 8-K on 2026-01-30 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, reasons for change, or any quantitative data such as compensation amounts are disclosed. No positive or negative metrics, financial impacts, or governance implications are mentioned.

30-01-2026

The company filed a Form 8-K on January 30, 2026 (AccNo: 0000950103-26-001305, Size: 186 KB) disclosing Item 8.01 Other Events as a General Filing. No specific details on the core event, financial metrics, transactions, or impacts are provided in the filing excerpt. No quantitative data, named entities, or scheduled events are mentioned.

30-01-2026

Autoliv Inc filed an 8-K on January 30, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. This is a multi-item filing typical for earnings releases, with no quantitative data available for analysis.

30-01-2026

SunPower Inc. filed a Form 8-K on 2026-01-30 reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and Item 3.02 unregistered sales of equity securities, with Item 9.01 for financial statements and exhibits. This is a multi-item mandatory disclosure with no specific transaction details, dollar values, terms, or financial impacts provided. No positive or negative metrics, period-over-period changes, or strategic context were disclosed.

30-01-2026

Flagstar Bank, National Association filed a Form 8-K on January 30, 2026, disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet details, period-over-period comparisons, or guidance were mentioned. This is a standard earnings-related disclosure with no quantified metrics provided.

30-01-2026

ESS Tech, Inc. filed an 8-K on 2026-01-30 reporting Item 1.01 Entry into a Material Definitive Agreement and Item 9.01 Financial Statements and Exhibits. No details on the agreement, transaction value, financial impacts, or other metrics are disclosed. AccNo: 0001628280-26-004263; File Size: 1 MB.

• ·Sector: not specified
• ·Source: us_sec
• ·File Size: 1 MB
• ·Multi-item filing: Yes (Items 1.01 and 9.01)
• ·Mandatory disclosure under SEC 8-K rules for Item 1.01

30-01-2026

SSR Mining Inc. filed a Form 8-K on January 30, 2026 (AccNo: 0000947871-26-000074), reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the core events, transactions, financial metrics, or quantitative data provided in the filing summary. No positive or negative metrics, period-over-period comparisons, or guidance changes are disclosed.

30-01-2026

Brand Engagement Network Inc. filed a multi-item 8-K on January 30, 2026, disclosing entry into a material definitive agreement under Item 1.01, creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, and unregistered sales of equity securities under Item 3.02, with additional other events under Item 8.01. While the material agreement may signal strategic funding or partnership opportunities, the new financial obligation introduces potential debt risks and the equity sales raise shareholder dilution concerns. No quantitative details such as transaction values, share counts, or financial impacts were disclosed.

30-01-2026

FG Nexus Inc. filed an 8-K on January 30, 2026, reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details, financial metrics, transactions, or performance data are disclosed in the provided filing information.

30-01-2026

Mechanics Bancorp filed a Form 8-K on January 30, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific revenue, earnings, balance sheet metrics, period-over-period comparisons, or guidance details in the available summary. No positive or negative performance indicators were mentioned.

30-01-2026

GRI Bio, Inc. filed an 8-K on 2026-01-30 reporting under Item 1.01 entry into a material definitive agreement. Item 9.01 includes financial statements and exhibits. No specific details, financial metrics, transaction values, positive or negative changes, or other quantitative data are disclosed.

30-01-2026

FIRST NORTHERN COMMUNITY BANCORP filed an 8-K on January 30, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but specific revenue, earnings, balance sheet changes, or other quantitative metrics are NOT_DISCLOSED in the provided information. No positive or negative performance indicators, period-over-period comparisons, or guidance revisions are detailed.

30-01-2026

Bluejay Diagnostics, Inc. filed a Form 8-K on January 30, 2026, disclosing events under multiple items including Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing appears related to governance changes and shareholder vote outcomes, but no specific details on the nature of modifications, vote results, or financial impacts are provided. No quantitative metrics, positive or negative changes, or period-over-period comparisons are disclosed.

30-01-2026

DORIAN LPG LTD. filed an 8-K on January 30, 2026 (AccNo: 0001596993-26-000004), disclosing under Item 2.02 Results of Operations and Financial Condition, Item 7.01 Regulation FD Disclosure, and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary filing typical for earnings releases. No specific revenue, earnings, guidance, or other quantitative financial metrics are explicitly stated in the provided filing information.

30-01-2026

Lake Superior Acquisition Corp filed an 8-K on 2026-01-30 announcing under Item 1.01 entry into a material definitive agreement related to a merger/acquisition event. Item 9.01 discloses financial statements and exhibits, likely including pro forma information and the agreement itself. No specific transaction terms, financial metrics, parties beyond the filer, valuations, synergies, or impacts are detailed in the provided filing summary.

30-01-2026

Twin Hospitality Group Inc. filed a Form 8-K on 2026-01-30 under Item 3.01 announcing a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No financial metrics, transaction values, guidance changes, or other quantitative details are disclosed. Sector is not specified.

• ·Accession Number: 0001493152-26-004291
• ·Filing size: 212 KB

30-01-2026

Chevron Corp filed an 8-K on January 30, 2026 (AccNo: 0000093410-26-000019, Size: 766 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This constitutes a multi-item filing for financial results disclosure. No specific quantitative financial metrics, period-over-period comparisons, guidance, or other numerical data are disclosed.

• ·Event Type: Financial Results
• ·Source: us_sec
• ·Sector: not specified

30-01-2026

Flag Ship Acquisition Corp filed an 8-K on January 30, 2026, disclosing under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement of the registrant. Item 9.01 includes financial statements and exhibits. No specific details on parties, amounts, terms, or context such as merger financing are provided.

30-01-2026

NorthEast Community Bancorp, Inc./MD/ filed an 8-K on January 30, 2026 (AccNo: 0001104659-26-008167), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative financial metrics were disclosed in the provided filing information. This is a standard voluntary disclosure typically associated with quarterly or annual financial results announcement.

30-01-2026

Fat Brands, Inc. filed an 8-K on January 30, 2026 (AccNo: 0001493152-26-004289), reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing from the US market. No additional financial metrics, reasons for delisting, dollar values, or impacts were disclosed. This event signals a material regulatory compliance failure with no offsetting positive developments mentioned.

30-01-2026

Constellation Acquisition Corp I filed an 8-K on January 30, 2026, disclosing under Item 2.03 the creation of a direct financial obligation or off-balance sheet arrangement, under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, under Item 5.07 submission of matters to a vote of security holders, and under Item 9.01 financial statements and exhibits. No quantitative metrics, deal values, financial impacts, or specific transaction details are provided in the filing excerpt. No positive or negative performance metrics are mentioned.

30-01-2026

Exxon Mobil Corp filed a Form 8-K on January 30, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 7.01 for Regulation FD disclosure. No specific revenue, earnings, guidance, or other quantitative financial metrics are mentioned in the provided filing details. This is a standard voluntary earnings-related disclosure with no directional performance data available.

30-01-2026

Myseum, Inc. filed a Form 8-K on January 30, 2026 (AccNo: 0001213900-26-009816, Size: 263 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, transactions, financial metrics, or exhibits are disclosed in the provided filing information. This is a multi-item filing with limited visibility into content.

30-01-2026

LyondellBasell Industries N.V. filed a Form 8-K on January 30, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, guidance, or other quantitative metrics are mentioned in the provided filing details. This represents a standard earnings announcement filing with no disclosed directional performance indicators.

30-01-2026

RICHTECH ROBOTICS INC. filed an 8-K on January 30, 2026, disclosing entry into a material definitive agreement under Item 1.01 and unregistered sales of equity securities under Item 3.02. Item 8.01 reports other events, accompanied by financial statements and exhibits under Item 9.01. No specific transaction values, share counts, financial impacts, or detailed terms are disclosed.

30-01-2026

Winvest Group Ltd filed an 8-K on January 30, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or any quantitative impacts are disclosed. No positive or negative metrics are mentioned.

30-01-2026

Aon plc filed a Form 8-K on January 30, 2026 (AccNo: 0001628280-26-004273), disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No quantitative financial metrics, period-over-period comparisons, revenue, earnings, guidance, or other specific numbers are provided in the filing details. This represents a standard earnings-related disclosure without directional performance indicators.

30-01-2026

Verizon Communications Inc. filed a Form 8-K on January 30, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. This multi-item filing pertains to financial results with no specific revenue, earnings, guidance, or period-over-period comparisons detailed in the provided information. No quantitative metrics, positive or negative performance indicators, or balance sheet effects are disclosed.

30-01-2026

Designer Brands Inc. filed a Form 8-K on January 30, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific names, positions affected, reasons for changes, timing details, or quantitative data such as compensation amounts are disclosed in the provided filing information. No financial metrics, performance comparisons, or other impacts are mentioned.

30-01-2026

SoFi Technologies, Inc. filed an 8-K on January 30, 2026, reporting Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits provided under Item 9.01. No quantitative financial metrics, revenue figures, earnings, period-over-period changes, guidance, or other specific performance data are disclosed in the filing details. This is an informational disclosure typical for earnings releases, but lacks details to assess positive or negative performance.

• ·AccNo: 0001818874-26-000008
• ·File Size: 1 MB
• ·Event Type: Financial Results

30-01-2026

Church & Dwight Co Inc /DE/ filed an 8-K on 2026-01-30 reporting results of operations and financial condition under Item 2.02 and financial statements and exhibits under Item 9.01. No quantitative financial metrics, period-over-period comparisons, guidance, or other specific data were explicitly disclosed in the provided filing information. Sector details were not specified.

30-01-2026

Air Products & Chemicals, Inc. filed an 8-K on January 30, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure.

30-01-2026

Atlantic Union Bankshares Corp filed a Form 8-K on January 30, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing represents a voluntary disclosure likely including attached materials such as a press release or investor presentation. No financial metrics, transactions, guidance, or other quantitative details are specified in the filing information provided.

30-01-2026

Dominion Energy, Inc. filed an 8-K on January 30, 2026, reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with a document size of 9 MB, suggesting exhibits such as presentations or financial statements may be attached. No specific financial metrics, transactions, guidance, or events are detailed in the provided filing information.

• ·AccNo: 0001193125-26-030493

30-01-2026

Immunocore Holdings plc filed an 8-K on 2026-01-30 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any quantitative impacts are disclosed.

30-01-2026

CHOICEONE FINANCIAL SERVICES INC filed an 8-K on January 30, 2026 (AccNo: 0001193125-26-030504, Size: 2 MB), categorized as an Officer Change event, disclosing under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific details on the officer position affected, appointment or resignation, reasons for change, financial metrics, period-over-period comparisons, or quantitative data are explicitly stated in the provided filing information. Sector is not specified, and no positive or negative performance indicators are mentioned.

30-01-2026

IES Holdings, Inc. filed a Form 8-K on January 30, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), disclosing financial results. No specific revenue, earnings, guidance, or other quantitative metrics are mentioned in the provided filing summary. No positive or negative performance details, period-over-period comparisons, or strategic updates are disclosed.

30-01-2026

Colgate-Palmolive Co filed an 8-K on January 30, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 financial statements and exhibits. No specific revenue, earnings, margins, or period-over-period comparisons are detailed in the provided filing information. All quantitative financial metrics are NOT_DISCLOSED.

30-01-2026

Imperial Oil Ltd filed an 8-K on January 30, 2026, reporting Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, or other financial metrics are disclosed in the provided filing information. No period-over-period comparisons, guidance, or performance indicators (positive, negative, or flat) are mentioned.

• ·AccNo: 0000049938-26-000007
• ·File Size: 1 MB
• ·Sector: NOT_DISCLOSED

30-01-2026

Sierra Bancorp filed a Form 8-K on January 30, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the nature of the other events or contents of any exhibits are disclosed in the filing summary. This multi-item filing provides no quantitative metrics, financial impacts, or directional information.

30-01-2026

Coya Therapeutics, Inc. filed a Form 8-K on January 30, 2026 (AccNo: 0001193125-26-030531), reporting multiple items: Entry into a Material Definitive Agreement (Item 1.01), Unregistered Sales of Equity Securities (Item 3.02), Regulation FD Disclosure (Item 7.01), Other Events (Item 8.01), and Financial Statements and Exhibits (Item 9.01). This multi-item filing signals potentially significant developments, but no specific transaction details, financial metrics, dollar values, share counts, or impacts are disclosed in the provided information. No positive or negative quantitative metrics are available for balanced comparison.

30-01-2026

FIRST HAWAIIAN, INC. filed a Form 8-K on 2026-01-30 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative metrics were detailed in the provided filing information. This is an informational earnings-related disclosure with no directional financial impacts explicitly stated.

30-01-2026

Alpha Metallurgical Resources, Inc. filed a Form 8-K on January 30, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This constitutes a multi-item filing for financial results disclosure. No specific revenue, earnings, balance sheet metrics, period-over-period changes, or guidance details are disclosed in the provided filing information.

30-01-2026

Horizon Space Acquisition II Corp. filed an 8-K on 2026-01-30 disclosing other events under Item 8.01 and financial statements/exhibits under Item 9.01 in connection with a merger/acquisition event. No specific details on deal structure, parties involved, valuation, financial terms, synergies, regulatory pathway, or shareholder impacts are provided in the filing summary. No quantitative metrics, positive or negative performance indicators, or scheduled events are mentioned.

30-01-2026

Franklin Resources Inc filed an 8-K on January 30, 2026 (AccNo: 0000038777-26-000032, Size: 866 KB), reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results as a voluntary earnings-related disclosure. No specific quantitative financial metrics, period-over-period comparisons, guidance, or other details are mentioned.

30-01-2026

ALX Oncology Holdings Inc filed a Form 8-K on January 30, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details of the other event, financial metrics, transactions, or impacts are disclosed in the provided filing summary. This is a multi-item filing with no quantitative data or period-over-period comparisons mentioned.

30-01-2026

Cibus, Inc. filed a Form 8-K on January 30, 2026 (AccNo: 0001193125-26-030591, Size: 496 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary disclosure as Item 8.01 covers material events not specified in other items, with exhibits attached but details NOT_DISCLOSED. No financial metrics, transactions, or performance data are explicitly stated.

30-01-2026

WisdomTree, Inc. filed an 8-K on January 30, 2026, under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a multi-item filing announcing financial results, but detailed quantitative data is NOT_DISCLOSED.

• ·Filing Accession Number: 0001214659-26-000967
• ·Filing Size: 661 KB
• ·Sector: NOT_DISCLOSED

30-01-2026

Republic Bancorp Inc./KY/ filed an 8-K on January 30, 2026, under Item 2.02 disclosing Results of Operations and Financial Condition, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative metrics are mentioned in the provided filing information. This is a standard financial results disclosure with no directional performance indicators available.

30-01-2026

Leslie's, Inc. filed an 8-K on January 30, 2026, reporting a change in its certifying accountant under Item 4.01. The filing also includes financial statements and exhibits under Item 9.01. No specific details, such as the names of the prior or new accountants, reasons for the change, financial impacts, or quantitative metrics, are disclosed.

30-01-2026

Amgen Inc filed an 8-K on January 30, 2026, disclosing under Item 1.02 the termination of a material definitive agreement. Item 9.01 provides financial statements and exhibits. No specific details on the agreement, parties, financial impacts, or quantitative metrics are disclosed.

30-01-2026

Oppenheimer Holdings Inc. filed a Form 8-K on January 30, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, or period-over-period comparisons are detailed in the filing description. This appears to be a standard earnings-related disclosure without quantified metrics provided.

30-01-2026

Enzon Pharmaceuticals, Inc. filed an 8-K on January 30, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 3.03 material modifications to rights of security holders. Item 9.01 discloses financial statements and exhibits. No quantitative details, transaction values, or specific impacts are provided in the filing summary.

30-01-2026

ProMIS Neurosciences Inc. filed a Form 8-K on January 30, 2026, reporting under Item 1.01 entry into a material definitive agreement, under Item 3.02 unregistered sales of equity securities, under Item 8.01 other events, and under Item 9.01 financial statements and exhibits. While the material agreement may represent a strategic development, the unregistered equity sales could imply potential shareholder dilution. No specific transaction details, financial impacts, or quantitative metrics are disclosed.

30-01-2026

Akebia Therapeutics, Inc. filed an 8-K on January 30, 2026, disclosing under Item 1.01 entry into a material definitive agreement, under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 includes financial statements and exhibits. No specific details on transaction terms, financial impacts, or personnel changes are provided.

30-01-2026

ACM Research, Inc. filed a Form 8-K on January 30, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, or exhibits are disclosed. No quantitative metrics, positive or negative changes, or directional information are provided in the filing summary.

30-01-2026

Edible Garden AG Inc filed a Form 8-K on January 30, 2026 (AccNo: 0001477932-26-000522), reporting under Item 3.03 (Material Modifications to Rights of Security Holders), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing indicates governance and shareholder rights changes, but specific details on modifications, amendments, events, or exhibits are NOT_DISCLOSED. No quantitative financial impacts, positive or negative metrics, or directional biases are provided.

30-01-2026

Hudson Technologies Inc. (/NY) filed a Form 8-K on January 30, 2026 (AccNo: 0001104659-26-008337), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the events, transactions, financial metrics, or exhibits are disclosed in the filing summary. This appears to be a voluntary multi-item disclosure with no quantified impacts provided.

30-01-2026

Ultragenyx Pharmaceutical Inc. filed a Form 8-K on January 30, 2026, reporting under Item 8.01 Other Events (Accession No. 0001193125-26-030590, file size 155 KB). No specific details regarding the nature of the other event, financial impacts, transactions, or metrics are disclosed in the provided filing information. This appears to be a single-item voluntary disclosure.

30-01-2026

Actelis Networks Inc filed an 8-K on January 30, 2026 (AccNo: 0001213900-26-009889, Size: 214 KB), disclosing under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing for voluntary compliance with Regulation FD by publicly releasing material nonpublic information, with exhibits attached. No specific core event details, financial metrics, transactions, or quantitative impacts are disclosed.

30-01-2026

HERC Holdings Inc. filed an 8-K on January 30, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected (e.g., CEO, CFO), whether it was an appointment or resignation, reasons for the change (e.g., retirement, performance), internal/external status, timing, board composition impact, or any financial metrics were disclosed. This appears to be a routine governance disclosure with no quantified impacts provided.

30-01-2026

RED RIVER BANCSHARES INC filed an 8-K on January 30, 2026, reporting results of operations and financial condition under Item 2.02. The filing includes financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative metrics were disclosed in the provided filing information.

30-01-2026

Wolfspeed, Inc. filed an 8-K on January 30, 2026, reporting under Item 5.02 regarding departure of directors or certain officers, election/appointment of directors/officers, and compensatory arrangements; Item 3.02 on unregistered sales of equity securities; Item 8.01 other events; and Item 9.01 financial statements/exhibits. No specific details on the officer change—including key position, appointment/resignation status, reasons, or timing—are disclosed. No quantitative metrics, financial data, named individuals, or scheduled events are mentioned.

30-01-2026

Nelnet Inc filed an 8-K on January 30, 2026, under Item 7.01 for Regulation FD Disclosure. No specific details, financial metrics, transactions, or other quantitative data were disclosed in the provided filing summary. No positive, negative, or flat performance metrics were mentioned.

30-01-2026

GLOBAL PARTNERS LP filed a Form 8-K on January 30, 2026, reporting under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific core event, transaction details, financial metrics, or quantitative impacts are disclosed in the provided filing summary. This appears to be a multi-item voluntary disclosure primarily for Reg FD compliance, with exhibits attached.

30-01-2026

BKV Corp filed an 8-K on 2026-01-30 disclosing entry into a material definitive agreement under Item 1.01 and completion of an acquisition or disposition of assets under Item 2.01. The filing also covers unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). No specific parties, deal terms, financial metrics, positive or negative performance indicators, or quantitative data are disclosed in the provided filing information.